Thrivent Financial for Lutherans Reduces Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Thrivent Financial for Lutherans decreased its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 34.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 153,063 shares of the company’s stock after selling 81,827 shares during the quarter. Thrivent Financial for Lutherans owned about 2.45% of VanEck Pharmaceutical ETF worth $13,206,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Townsquare Capital LLC increased its holdings in shares of VanEck Pharmaceutical ETF by 3.8% during the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after buying an additional 130 shares during the last quarter. FMR LLC raised its position in VanEck Pharmaceutical ETF by 12.5% in the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares during the period. NTV Asset Management LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 3.6% in the 4th quarter. NTV Asset Management LLC now owns 7,709 shares of the company’s stock valued at $665,000 after purchasing an additional 271 shares during the last quarter. SBI Securities Co. Ltd. purchased a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth $29,000. Finally, Activest Wealth Management acquired a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $32,000.

VanEck Pharmaceutical ETF Price Performance

NASDAQ PPH opened at $92.64 on Friday. The stock has a market capitalization of $578.07 million, a P/E ratio of 27.82 and a beta of 0.72. The firm’s 50-day moving average is $90.22 and its two-hundred day moving average is $91.03. VanEck Pharmaceutical ETF has a 12 month low of $84.48 and a 12 month high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were given a dividend of $0.411 per share. The ex-dividend date of this dividend was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.